Application no. and date | 14780512.1 (espacenet) (Federated) (European Patent Register), 20141003 | Patent/reg. no. and date | DK/EP 3055325, 20180103 | Publication date | 20160817 | Priority no. and date | EP 13187626, 20131007 | EP pub. no. and date |
EP 3055325 20160817 | Effective date | | Applicant/owner | Novo Nordisk A/S, Novo Allé 1, 2880 Bagsværd, DK | Applicant ref. no. | P23318DKEP | Inventor | NAVER, Helle, Novo Nordisk A/S Novo Allé, 2880 Bagsværd, DK, TAGMOSE, Tina Møller, Novo Nordisk A/S Novo Allé, 2880 Bagsværd, DK, MADSEN, Peter, Novo Nordisk A/S Novo Allé, 2880 Bagsværd, DK, KJELDSEN, Thomas Børglum, Novo Nordisk A/S Novo Allé, 2880 Bagsværd, DK | Representative | Patrade A/S, Ceresbyen 75, 8000 Århus C | Opponent | | IPC Class | A61K 38/28 (2006.01) , C07K 14/62 (2006.01) | Title | Nyt derivat af en insulinanalog | Int. application no. | EP2014071236 | Int. publication no. | WO2015052088 | Related patent (certificate) | | Status | Bortfaldet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|